The Neptune product recall was only one of the recalls issued by Stryker last year. The company also announced the Stryker hip replacement recall for Rejuvenate and ABG II hip components.
New York, NY (PRWEB) March 14, 2013
As Stryker hip lawsuits related to the recent recall of Rejuvenate and ABG II Modular-Neck Stems continue to mount in courts throughout the country, the company is facing more trouble over its handling of another problematic product, Bernstein Liebhard LLP reports. According to Reuters, Stryker announced earlier this week that it had received a warning letter from the U.S. Food & Drug Administration (FDA) for failing to inform the agency of a recall involving its Neptune surgical waste management system, and for marketing devices without required approvals. The FDA warning letter also cited quality problems at a manufacturing facility in Portage, Michigan. *
“The Neptune product recall was only one of the recalls issued by Stryker last year. The company also announced the Stryker hip replacement recall for Rejuvenate and ABG II hip components. These recalls, along with the news of the FDA warning letter, are certainly concerning,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including clients who have filed Stryker hip lawsuits. The Firm is offering free Stryker hip replacement lawsuit evaluations to recipients of the recalled Rejuvenate and ABG II hip stems
Stryker Hip Replacement Lawsuit
Stryker recalled its Rejuvenate and ABG II hip stems in July 2012, after data indicated the metal hip components were vulnerable to fretting and corrosion at the modular neck junction. When this occurs, Stryker hip replacement recipients may experience pain, swelling and adverse local tissue reactions. Since the recall, all Rejuvenate and ABG II hip stem recipients have been advised to undergo metal ion testing and cross sectional imaging, even if they are not experiencing symptoms of a failing hip implant. Stryker issued this advice after the company received reports that some patients had experienced high levels of metal ions in their blood and/or adverse local tissue reactions, even in the absence of symptoms.**
According to the company’s recall notice, 20,000 of the affected Stryker hip replacement components had been sold globally prior to the recall.*** Court records indicate that a growing number of Stryker hip lawsuits have since been filed, all of which allege Stryker sold a defective product. In January, the New Jersey Supreme Court established a multicounty litigation in Bergen County Superior Court for all pending and future Stryker hip lawsuits filed in the state. As of February 20, at least 81 claims were pending in the consolidated proceeding. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296).
According to a February 19th petition filed with the U.S. Judicial Panel on Multidistrict Litigation, some plaintiffs have requested that all federally-filed Stryker hip replacement lawsuits be transferred to the U.S. District Court, District of Minnesota. The Petition states that at least 30 claims have been filed against Stryker in various federal districts, and asserts that many more could be filed in the future. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML))
Individuals who have suffered hip implant failures, metal poisoning, pain, or revision surgery allegedly due to the recalled Stryker hip components may be entitled to compensation for their medical care, pain and suffering, and other damages. A wealth of information regarding Stryker hip replacement lawsuits is available at Bernstein Liebhard LLP’s website, http://www.consumerinjurylawyers.com. Free lawsuit evaluations can be obtained by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP